1. Patai, S., The Chemistry of the Quinonoid Compounds, Parts 1, 2, New York: Wiley, 1974.
2. Komiyama, T., Kikuchi, T., and Sugiura, Y., Interactions of anticancer quinone drugs, aclacinomycin A, adriamycin, carbazilquinone, and mitomycin C, with NADPH-cytochrome P-450 reductase, xanthine oxidase and oxygen, J. Pharmacobio-dyn., 1986, vol. 9, p. 651.
3. Hijazi, Y. and Boulieu, R., Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes, Drug Metab. Dispos., 2002, vol. 30, p. 853.
4. Peck, T.E., Hill, S.A., and Williams, M., Pharmacology for Anaesthesia and Intensive Care, 3rd ed., Cambridge: Cambridge University Press, 2008.
5. Bergman, S.A., Ketamine: review of its pharmacology and its use in pediatric anesthesia, Anesth. Prog., 1999, vol. 46, p. 10.